High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

Australia was one of the first countries with unrestricted access to government subsidized direct‐acting antiviral (DAA) therapy for adults with chronic hepatitis C virus. This study assessed real‐world DAA treatment outcomes across a diverse range of Australian clinical services and evaluated facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Jasmine, Carson, Joanne M., Hajarizadeh, Behzad, Hanson, Joshua, O’Beirne, James, Iser, David, Read, Phillip, Balcomb, Anne, Doyle, Joseph S., Davies, Jane, Martinello, Marianne, Marks, Philiipa, Dore, Gregory J., Matthews, Gail V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870316/
https://www.ncbi.nlm.nih.gov/pubmed/34729957
http://dx.doi.org/10.1002/hep4.1826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870316/
https://www.ncbi.nlm.nih.gov/pubmed/34729957
http://dx.doi.org/10.1002/hep4.1826

Ejemplares similares